A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer

被引：0
|
作者：
George Fountzilas
Anna Fragkoulidi
Anna Kalogera-Fountzila
Martha Nikolaidou
Mattheos Bobos
Julien Calderaro
Felipe Andreiuolo
Marios Marselos
机构：
[1] Aristotle University of Thessaloniki School of Medicine,Department of Medical Oncology, “Papageorgiou” Hospital
[2] Aristotle University of Thessaloniki School of Medicine,Department of Radiology, AHEPA Hospital
[3] University of Ioannina School of Medicine,Department of Pharmacology
[4] Aristotle University of Thessaloniki School of Medicine,Department of Pathology
[5] Institut de Cancerologie Gustave Roussy,Translational Research Laboratory
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 65卷
关键词：
Head and neck cancer; Pharmacokinetic analysis; Sunitinib; Angiogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：649 / 660
页数：11
相关论文
共 50 条
  • [1] A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer
    Fountzilas, George
    Fragkoulidi, Anna
    Kalogera-Fountzila, Anna
    Nikolaidou, Martha
    Bobos, Mattheos
    Calderaro, Julien
    Andreiuolo, Felipe
    Marselos, Marios
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (04) : 649 - 660
  • [2] Phase II study of rubitecan in recurrent or metastatic head and neck cancer
    Francesco Caponigro
    Giacomo Cartenì
    Jean Pierre Droz
    Amalia Milano
    Wayne B. Davis
    Patricia Pollard
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 209 - 214
  • [3] Phase II study of rubitecan in recurrent or metastatic head and neck cancer
    Caponigro, Francesco
    Carteni, Giacomo
    Droz, Jean Pierre
    Milano, Amalia
    Davis, Wayne B.
    Pollard, Patricia
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) : 209 - 214
  • [4] Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer
    Tsao, Anne
    Hui, Edwin Pun
    Juergens, Rosalyn
    Marur, Shanthi
    Huat, Tan Eng
    Cher, Goh Boon
    Hong, Ruey-Long
    Hong, Waun Ki
    Chan, Anthony Tak-Cheung
    CANCER MEDICINE, 2013, 2 (03): : 351 - 359
  • [5] Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group
    Fountzilas, G
    Stathopoulos, G
    Nicolaides, C
    Kalogera-Fountzila, A
    Kalofonos, H
    Nikolaou, A
    Bacoyiannis, C
    Samantas, E
    Papadimitriou, C
    Kosmidis, P
    Daniilidis, J
    Pavlidis, N
    ANNALS OF ONCOLOGY, 1999, 10 (04) : 475 - 478
  • [6] Phase II trial of sunitinib in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Choong, N. W.
    Cohen, E. E.
    Kozloff, M. F.
    Taber, D.
    Wade, J. L., III
    Hu, S.
    Ivy, S. P.
    Nichols, K.
    Dekker, A.
    Vokes, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase II study of sunitinib in patients with recurrent and/or metastatic squamous head and neck carcinoma: The GORTEC 2006-01 study
    Machiels, J. H.
    Henry, S.
    Zanetta, S.
    Kaminsky, M.
    Michoux, N.
    Bompas, E.
    Dillies, A.
    Faivre, S.
    Schmitz, S.
    Guigay, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer
    Paul L. Swiecicki
    Lili Zhao
    Emily Belile
    Assuntina G. Sacco
    Douglas B. Chepeha
    Irina Dobrosotskaya
    Matthew Spector
    Andrew Shuman
    Kelly Malloy
    Jeffrey Moyer
    Erin McKean
    Scott McLean
    Gregory T. Wolf
    Avraham Eisbruch
    Mark Prince
    Carol Bradford
    Thomas Carey
    Francis P. Worden
    Investigational New Drugs, 2015, 33 : 1248 - 1256
  • [9] A phase II trial of perifosine in patients with recurrent or metastatic head and neck cancer
    Argiris, A
    Cohen, EEW
    Wade, J
    Mauer, A
    Gustin, D
    Ansari, R
    Wong, S
    Karrison, T
    Vokes, E
    LUNG CANCER, 2004, 46 : S66 - S66
  • [10] A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer
    Swiecicki, Paul L.
    Zhao, Lili
    Belile, Emily
    Sacco, Assuntina G.
    Chepeha, Douglas B.
    Dobrosotskaya, Irina
    Spector, Matthew
    Shuman, Andrew
    Malloy, Kelly
    Moyer, Jeffrey
    McKean, Erin
    McLean, Scott
    Wolf, Gregory T.
    Eisbruch, Avraham
    Prince, Mark
    Bradford, Carol
    Carey, Thomas
    Worden, Francis P.
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (06) : 1248 - 1256
12345